We confirmed that the mRNA expression of a list of previously published CTA (29), including CTAG1A/B that encode for NY-ESO-1 antigen, were downregulated in the majority of the 153 TCGA_GBM samples. The gene discussed is CTAG1A; the disease is glioblastoma.